<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>MYC-family protein overexpression and prominent nucleolar formation represent prognostic indicators and potential therapeutic targets for aggressive high-MKI neuroblastomas: a report from the children's oncology group.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="MYC-family protein overexpression and prominent nucleolar formation represent prognostic indicators and potential therapeutic targets for aggressive high-MKI neuroblastomas: a report from the children's oncology group." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814222/bin/oncotarget-09-6416-g001.jpg"/> </div> <div class="text-side"> <h1>MYC-family protein overexpression and prominent nucleolar formation represent prognostic indicators and potential therapeutic targets for aggressive high-MKI neuroblastomas: a report from the children's oncology group.</h1> <p>Examples of neuroblastoma, undifferentiated and poorly differentiated subtype with a High Mitosis-Karyorrhexis Index(A) Tumor in the MYCN amplified group (FISH, Original × 1,000) Green = 2p23-24 MYCN region probe; Red = CEP 2 region probe. (B) Tumor in the MYCN non-MYCN amplified group (FISH, Original × 1,000) Green = 2p23-24 MYCN region probe; Red = CEP 2 region probe. (C) Tumor with prominent nucleolar formation (H&amp;E, Original x600). (D) Tumor without prominent nucleolar formation (H&amp;E, Original x600). (E) Tumor expressing MYCN protein (+) (Immunostaining without counterstaining, Original × 600). (F) Tumor with MYCN protein (+/−) (Immunostaining without counterstaining, Original × 600). (G) Tumor with MYCN protein (−) (Immunostaining without counterstaining, Original × 600). (H) Tumor expressing MYC protein (+) (Immunostaining with Hematoxylin counterstaining, Original × 600). (I) Tumor with MYC protein (+/−) (Immunostaining with Hematoxylin counterstaining, Original x600). (J) Tumor with MYC protein (−) Note activated endothelial cells positive for MYC protein (Immunostaining with Hematoxylin counterstaining, Original × 600).</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/29464082/" target="_blank">29464082</a></p><p>Type: Premalignant/Malignant, Category: Neural or neuroendocrine</p>
</div> </div></div></body></html>